Clinical Trial Continuity through the COVID-19 Pandemic Keep clinical trials moving in today’s environment


Sponsored Content

Clinical trials are being impacted by COVID-19 as investigator sites cannot accept visits from patients, CRAs or even site personnel. IQVIA is working with agencies and sponsors to adapt operational processes and move trials to remote monitoring capabilities in a virtual trial approach. Live: Thursday, May 7, 2020 at 11am EDT On demand available after airing until May 7, 2021. Register free

Register free:

Event Overview:

The outbreak of COVID-19 has affected each of us in many ways. In clinical trials, site visits by patients, CRAs and site personnel have been severely restricted or cancelled.  This fast-changing situation has led us to re-evaluate how we adapt our monitoring models to continue to help our customers bring potential healthcare treatments to patients.

Join this timely and insightful webinar to understand how we are coordingating with local health authorities and customers to deploy, when appropriate, our services and technologies to further increase remote-based CRA and Centralized monitoring for trials, remote patient visits (aka virtual trials), supply logistics and other remote interactions between patients and HCPs to enable study continuity on a global bases.

Learn how the use of technology and innovative approaches is keeping clinical trials on track while enhancing the safety and quality of those involved by automating digital processes, including: 

  • Delivering transformative tools like IQVIA COVID Active Research Experience (CARE) Project and COVID-19 Trial Matching Solution

  • Utilizing IQVIA’s virtual trials execution platform Study Hub to enable televisits and eDiary

  • Rapidly implementing remote and risk-based monitoring principles

  • Conducting active/on-going risk assessment and mitigation exercises

Register today and hear how companies are transforming their processes and driving continuity in their clinical development efforts!

3 Key Take-Aways

  • COVID-19 is impacting clinical trials, but IQVIA is helping sponsors keep trials on track with new process models, tools and platforms to advance the development of treatments and vaccines against this disease 

  • Implementing remote monitoring in a virtual trial approach, IQVIA is enhancing patient, site and CRA safety while maintaining trial timelines

  • Technology with automated processes are helping to rapidly pivot traditional monitoring models into remote and virtual elements and lend continuity of trial conduct

Speakers: Rajneesh Patil, Senior Director, Head – Process Design & Analytics Centralized Monitoring Services, IQVIA

Christopher Varner, Virtual Trials Project Manager, IQVIA

Time and date: Thursday, May 7, 2020 at 11am EDT

On demand available after airing until May 7, 2021.

Sponsor: IQVIA 

Register free:

Related Content
© 2024 MJH Life Sciences

All rights reserved.